 |
|
Survival analysis: Part II — applied clinical data analysis
Junyong In, Dong Kyu Lee
Korean J Anesthesiol. 2023;76(1):84-85. Published online 2023 Jan 4 DOI: https://doi.org/10.4097/kja.19183.e1
|
|
Citations to this article as recorded by
 ORC6 acts as an effective prognostic predictor for non‑small cell lung cancer and is closely associated with tumor progression
Letian Chen, Dongdong Zhang, Yujuan Chen, Huilan Zhu, Zhipeng Liu, Zhiping Yu, Junping Xie
Oncology Letters.2024;[Epub] CrossRef Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study
Marin Guigo, Mohammed Sali Dauda, Justine Lequesne, Alice Blache, Renata Pereira, Ioana Le Gall, Victor Emmanuel Pernin, Léopold Gaichies, Bénédicte Clarisse, Jean-Michel Grellard, Florence Joly, Emmanuel Meyer, Jacques Balosso
Frontiers in Oncology.2024;[Epub] CrossRef Associations between an obesity-related dietary pattern and incidence of overall and site-specific cancers: a prospective cohort study
Maiwulamujiang Maimaitiyiming, Hongxi Yang, Lihui Zhou, Xinyu Zhang, Qiliang Cai, Yaogang Wang
BMC Medicine.2023;[Epub] CrossRef BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer
Hongbiao Luo, Ji Luo, Ning Ding, Tao Zhang, Yongheng He
Pharmacogenomics and Personalized Medicine.2023; Volume 16: 1109. CrossRef
|